← Back to headlines
Eli Lilly Eyes More Dealmaking to Capitalize on GLP-1 Success
Eli Lilly's management is reportedly looking to pursue additional dealmaking opportunities to further leverage the success of its GLP-1 drugs.
4 Jun, 13:47 — 4 Jun, 13:47
Sources
Showing 1 of 1 sources
